| Workit Health (mi), Pllc | |
|
11800 Singletree Ln Ste 303 Eden Prairie MN 55344-5398 | |
| (651) 349-4342 | |
| Not Available |
| Full Name | Workit Health (mi), Pllc |
|---|---|
| Speciality | Clinic/Center |
| Location | 11800 Singletree Ln Ste 303, Eden Prairie, Minnesota |
| Authorized Official Name and Position | Paul Leonard (OWNER, MANAGER) |
| Authorized Official Contact | 4158429771 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Workit Health (mi), Pllc 3300 Washtenaw Ave Ste 280 Ann Arbor MI 48104-5184 Ph: (415) 842-9771 | Workit Health (mi), Pllc 11800 Singletree Ln Ste 303 Eden Prairie MN 55344-5398 Ph: (651) 349-4342 |
| NPI Number | 1659946028 |
|---|---|
| Provider Enumeration Date | 05/26/2021 |
| Last Update Date | 03/17/2022 |
| Medicare PECOS PAC ID | 6406101625 |
|---|---|
| Medicare Enrollment ID | O20220301000136 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced positive top-line results from the IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) Phase III clinical program of XIAFLEX for the treatment of Peyronie's disease, which was conducted by BioSpecifics' partner Auxilium Pharmaceuticals, Inc.
Roll Call: "Speaker Nancy Pelosi (D-Calif.) dismissed as a 'nonissue' a procedural maneuver House Democrats are eyeing to pass their health care overhaul in the wake of comments by Rep. Stephen Lynch (D-Mass.) that the move would be 'disingenuous' and harm Congressional credibility. House Democrats are considering a process that would allow them to avoid a separate vote on the unpopular Senate version of reform by deeming that measure passed once they approve a package of changes to it.
Removing a brain tumor requires walking a fine line: Remove too little, and the disease remains; remove too much, and sight, speech or movement may be impaired.
Scott & White Healthcare in Temple is one of three sites chosen for a $1.6 million initiative to create internships for doctoral psychology students that will help alleviate mental health workforce shortages in Texas.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659946028 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
| Provider Name | Donald Dunow |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013047463 PECOS PAC ID: 0143458158 Enrollment ID: I20180620000658 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced positive top-line results from the IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) Phase III clinical program of XIAFLEX for the treatment of Peyronie's disease, which was conducted by BioSpecifics' partner Auxilium Pharmaceuticals, Inc.
Roll Call: "Speaker Nancy Pelosi (D-Calif.) dismissed as a 'nonissue' a procedural maneuver House Democrats are eyeing to pass their health care overhaul in the wake of comments by Rep. Stephen Lynch (D-Mass.) that the move would be 'disingenuous' and harm Congressional credibility. House Democrats are considering a process that would allow them to avoid a separate vote on the unpopular Senate version of reform by deeming that measure passed once they approve a package of changes to it.
Removing a brain tumor requires walking a fine line: Remove too little, and the disease remains; remove too much, and sight, speech or movement may be impaired.
Scott & White Healthcare in Temple is one of three sites chosen for a $1.6 million initiative to create internships for doctoral psychology students that will help alleviate mental health workforce shortages in Texas.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 8 days ago
| Provider Name | Soha Alammoury |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750730834 PECOS PAC ID: 1557655859 Enrollment ID: I20220517001693 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced positive top-line results from the IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) Phase III clinical program of XIAFLEX for the treatment of Peyronie's disease, which was conducted by BioSpecifics' partner Auxilium Pharmaceuticals, Inc.
Roll Call: "Speaker Nancy Pelosi (D-Calif.) dismissed as a 'nonissue' a procedural maneuver House Democrats are eyeing to pass their health care overhaul in the wake of comments by Rep. Stephen Lynch (D-Mass.) that the move would be 'disingenuous' and harm Congressional credibility. House Democrats are considering a process that would allow them to avoid a separate vote on the unpopular Senate version of reform by deeming that measure passed once they approve a package of changes to it.
Removing a brain tumor requires walking a fine line: Remove too little, and the disease remains; remove too much, and sight, speech or movement may be impaired.
Scott & White Healthcare in Temple is one of three sites chosen for a $1.6 million initiative to create internships for doctoral psychology students that will help alleviate mental health workforce shortages in Texas.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 8 days ago
| Provider Name | Amy Vetter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730792664 PECOS PAC ID: 5799162269 Enrollment ID: I20220523001703 |
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced positive top-line results from the IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) Phase III clinical program of XIAFLEX for the treatment of Peyronie's disease, which was conducted by BioSpecifics' partner Auxilium Pharmaceuticals, Inc.
Roll Call: "Speaker Nancy Pelosi (D-Calif.) dismissed as a 'nonissue' a procedural maneuver House Democrats are eyeing to pass their health care overhaul in the wake of comments by Rep. Stephen Lynch (D-Mass.) that the move would be 'disingenuous' and harm Congressional credibility. House Democrats are considering a process that would allow them to avoid a separate vote on the unpopular Senate version of reform by deeming that measure passed once they approve a package of changes to it.
Removing a brain tumor requires walking a fine line: Remove too little, and the disease remains; remove too much, and sight, speech or movement may be impaired.
Scott & White Healthcare in Temple is one of three sites chosen for a $1.6 million initiative to create internships for doctoral psychology students that will help alleviate mental health workforce shortages in Texas.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 8 days ago
News Archive
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced positive top-line results from the IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) Phase III clinical program of XIAFLEX for the treatment of Peyronie's disease, which was conducted by BioSpecifics' partner Auxilium Pharmaceuticals, Inc.
Roll Call: "Speaker Nancy Pelosi (D-Calif.) dismissed as a 'nonissue' a procedural maneuver House Democrats are eyeing to pass their health care overhaul in the wake of comments by Rep. Stephen Lynch (D-Mass.) that the move would be 'disingenuous' and harm Congressional credibility. House Democrats are considering a process that would allow them to avoid a separate vote on the unpopular Senate version of reform by deeming that measure passed once they approve a package of changes to it.
Removing a brain tumor requires walking a fine line: Remove too little, and the disease remains; remove too much, and sight, speech or movement may be impaired.
Scott & White Healthcare in Temple is one of three sites chosen for a $1.6 million initiative to create internships for doctoral psychology students that will help alleviate mental health workforce shortages in Texas.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 8 days ago
Rogers Behavioral Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6442 City West Pkwy Ste 200, Eden Prairie, MN 55344 Phone: 844-599-8959 Fax: 763-318-2801 | |
Awakening Wholeness Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9300 Hennepin Town Rd Ste B, Eden Prairie, MN 55347 Phone: 303-521-6463 | |
Nura Mobile Medicine Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 10067 Gristmill Rdg, Eden Prairie, MN 55347 Phone: 612-226-2747 | |
Medexpress Primary Care Minnesota Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 11000 Optum Circle, Eden Prairie, MN 55344 Phone: 952-205-2170 | |
Oak Support Services Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6385 Old Shady Oak Rd Ste 250, Eden Prairie, MN 55344 Phone: 210-810-5858 | |
Odom Health & Wellness Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 6545 Flying Cloud Dr Ste 201, Eden Prairie, MN 55344 Phone: 952-224-1919 | |
Fairview Clinics-eden Prairie Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 830 Prairie Center Dr, Eden Prairie, MN 55344 Phone: 952-826-6500 Fax: 952-826-6515 |